Filing Flows › Envoy Medical (COCH) › Q1 2025
Envoy Medical (COCH) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
Envoy Medical (COCH) reported revenue of $46K for the first quarter 2025 (Q1 2025), -22% from a year earlier and +10% from the quarter before.
Envoy Medical, Q1 2025: revenue $46K (-22% year over year), net loss $5.0M, operating cash flow −$3.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $46K | +10% | -22% |
| Operating profit | −$5.1M | — | — |
| Net earnings | −$5.0M | — | — |
| Operating cash flow | −$3.7M | — | — |
What changed
Revenue was $46K in Q1 2025, down 22% year over year and up 10% from the previous quarter.
Operating costs exceeded revenue by $5.1M, an operating margin of -11102.2%. Total costs grew 4% against a revenue fall of 22%. The fastest-growing cost line was Cost of revenue (+48%). The quarter ended with a net loss of $5.0M, wider than the previous quarter's $4.6M loss.
Operating cash flow was −$3.7M. Non-cash charges added back $61K of depreciation and $160K of share-based compensation. Working capital and other items added $1.1M. Capital expenditures of $6K exceeded it, leaving free cash flow of −$3.7M.
Questions
What was Envoy Medical's revenue in the first quarter 2025?
Envoy Medical (COCH) reported revenue of $46K for the first quarter 2025 (Q1 2025), -22% from a year earlier and +10% from the quarter before.
Source: Envoy Medical 10-Q on SEC EDGAR.